ASCO News: Cemiplimab (Libtayo, Regeneron Pharmaceuticals, Inc.) Performs Well in High-risk cSCC in the Adjuvant Setting

June 2, 2025

ASCO 2025: DecisionDx-Melanoma Provides More Precise Mortality Risk Predictions for Melanoma Patients

May 30, 2025

Edible Sunscreens: What Your Patients Need to Know Now

May 30, 2025

Novel Biomarker Linked to cSCC Metastasis

May 29, 2025

Milestone Alert: More Than 300,000 Patients With Suspicious Lesions Have Been Assessed Using Nevisense

May 27, 2025

AI Medical Technology’s Dermalyser Earns CE Mark in Europe

May 27, 2025

New Nanoencapsulated CBD Cream Protects Against UVA-Induced Skin Damage

May 23, 2025

ASCO Skin Cancer News: Lifileucel Boosts Five-year Survival Rates in Advanced Melanoma

May 23, 2025

Study: The Global Disease Burden of Skin Cancer in Older People Is on the Rise

May 22, 2025

Skin Cancer Treatment Success Stories: Investigational WTX-124 Induces Remission for Man With Advanced cSCC

May 21, 2025

U.S. FDA Approves Sun Pharma’s Next Generation BLU-U Blue Light PDT Illuminator for AK

May 17, 2025

Skin Cancer Awareness Month Company Spotlight: Coolibar

May 13, 2025